These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26268339)
1. Non-Zinc-Binding Inhibitors of MMP-13: GRID-Based Approaches to Rationalize the Binding Process. Di Pizio A; Agamennone M; Tortorella P Curr Top Med Chem; 2016; 16(4):449-59. PubMed ID: 26268339 [TBL] [Abstract][Full Text] [Related]
2. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis. Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376 [TBL] [Abstract][Full Text] [Related]
3. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents. Xie XW; Wan RZ; Liu ZP ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301 [TBL] [Abstract][Full Text] [Related]
4. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8. Kalva S; Vinod D; Saleena LM J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550 [TBL] [Abstract][Full Text] [Related]
5. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme. Ramezani M; Shamsara J Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230 [TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors. Choi JY; Fuerst R; Knapinska AM; Taylor AB; Smith L; Cao X; Hart PJ; Fields GB; Roush WR J Med Chem; 2017 Jul; 60(13):5816-5825. PubMed ID: 28653849 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors. Nara H; Sato K; Kaieda A; Oki H; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M Bioorg Med Chem; 2016 Dec; 24(23):6149-6165. PubMed ID: 27825552 [TBL] [Abstract][Full Text] [Related]
8. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors. Di Pizio A; Laghezza A; Tortorella P; Agamennone M ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724 [TBL] [Abstract][Full Text] [Related]
9. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies. Fischer T; Riedl R Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528 [TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7. Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131 [TBL] [Abstract][Full Text] [Related]
11. Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor. Senn N; Ott M; Lanz J; Riedl R J Med Chem; 2017 Dec; 60(23):9585-9598. PubMed ID: 28953404 [TBL] [Abstract][Full Text] [Related]
12. Identification of Non-Zinc Binding Inhibitors of MMP-2 Through Virtual Screening and Subsequent Rescoring. Shamsara J Drug Res (Stuttg); 2018 Sep; 68(9):529-535. PubMed ID: 29614516 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results. Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623 [TBL] [Abstract][Full Text] [Related]
14. Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies. Ammazzalorso A; De Filippis B; Campestre C; Laghezza A; Marrone A; Amoroso R; Tortorella P; Agamennone M Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782083 [TBL] [Abstract][Full Text] [Related]
15. Identification of Cuffaro D; Gimeno A; Bernardoni BL; Di Leo R; Pujadas G; Garcia-Vallvé S; Nencetti S; Rossello A; Nuti E Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446276 [TBL] [Abstract][Full Text] [Related]
16. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors. Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775 [TBL] [Abstract][Full Text] [Related]
17. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448 [TBL] [Abstract][Full Text] [Related]
18. Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study. Singh T; Adekoya OA; Jayaram B Mol Biosyst; 2015 Apr; 11(4):1041-51. PubMed ID: 25611160 [TBL] [Abstract][Full Text] [Related]
19. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors. Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065 [TBL] [Abstract][Full Text] [Related]
20. Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies. Nuti E; Cuffaro D; Bernardini E; Camodeca C; Panelli L; Chaves S; Ciccone L; Tepshi L; Vera L; Orlandini E; Nencetti S; Stura EA; Santos MA; Dive V; Rossello A J Med Chem; 2018 May; 61(10):4421-4435. PubMed ID: 29727184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]